Literature DB >> 1648579

Cachexia and tumour necrosis factor-alpha in cytomegalovirus infection.

H Tilg1, W Vogel, M Herold, W E Aulitzky, C Huber.   

Abstract

Although cachexia is a common feature of cytomegalovirus infection, little is known about its cause. To explore any contributory role that tumour necrosis factor-alpha (TNF) might have the serum concentrations of TNF in eight patients who developed CMV disease after liver transplantation were investigated. All patients exhibited pronounced and long lasting increases in TNF serum concentrations. Increased endogenous TNF concentrations were associated with weight loss and anorexia. In contrast, liver transplant recipients without CMV disease showed no weight loss.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648579      PMCID: PMC496839          DOI: 10.1136/jcp.44.6.519

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

2.  Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation.

Authors:  H Tilg; W Vogel; W E Aulitzky; M Herold; A Königsrainer; R Margreiter; C Huber
Journal:  Transplantation       Date:  1990-06       Impact factor: 4.939

Review 3.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

4.  Cachectic effects of recombinant human tumor necrosis factor in rats.

Authors:  G Darling; D L Fraker; J C Jensen; C M Gorschboth; J A Norton
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

5.  Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models.

Authors:  B A Sherry; J Gelin; Y Fong; M Marano; H Wei; A Cerami; S F Lowry; K G Lundholm; L L Moldawer
Journal:  FASEB J       Date:  1989-06       Impact factor: 5.191

6.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

Authors:  K J Tracey; H Wei; K R Manogue; Y Fong; D G Hesse; H T Nguyen; G C Kuo; B Beutler; R S Cotran; A Cerami
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

  6 in total
  4 in total

1.  The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.

Authors:  S T Yerkovich; S D Olver; J C Lenzo; C D Peacock; P Price
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Interleukin-1 production and cell-activation response to cytomegalovirus infection of vascular endothelial cells.

Authors:  S B Woodroffe; H M Garnett; V A Danis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.

Authors:  H Schönbohn; M Schuler; K Kolbe; C Peschel; C Huber; W Bemb; W E Aulitzky
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

4.  Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus.

Authors:  B L Haagmans; F S Stals; P H van der Meide; C A Bruggeman; M C Horzinek; V E Schijns
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.